Completed PHASE4 INTERVENTIONAL 1-arm NCT02180737

Dexmedetomidine for Sedation During Radiological Interventional Procedures (Dexmed)

Evaluation of Role of Dexmedetomidine as a Sole Agent in Sedation of Cancer Patients Undergoing Radiological Interventional Procedures

Sponsor: National Cancer Institute, Egypt

Conditions Procedural Sedation

Interventions Dexmeditomedine

Updated 6 times since 2017 Last updated: Apr 17, 2016 Started: Jan 31, 2014 Primary completion: Dec 31, 2014 Completion: Jan 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Procedural Sedation, this trial is completed. The trial is conducted by National Cancer Institute, Egypt and has accumulated 6 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Jan 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Cancer Institute, Egypt

Data source: National Cancer Institute, Egypt

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt